News Release

CME Group Names David Boberski as Managing Director, OTC Research and New Product Development

Thu Feb 26 2009

CHICAGO, Feb. 26 /PRNewswire-FirstCall/ -- CME Group, the world's largest and most diverse derivatives exchange, today announced that it has named David Boberski as Managing Director, OTC Research and New Product Development. In this newly created position, Boberski, 33, will be responsible for identifying and developing new product opportunities in credit and interest rates, adapting existing CME Group products and services to the over-the-counter (OTC) markets and educating CME Group customers on CME Group credit and interest rate products. He will report to Julie Winkler, Managing Director, Research and Product Development.


Prior to joining CME Group, Boberski served as Executive Director and Head of Exchange Traded Derivatives Research for UBS Investment Bank and Managing Director, Principal and Head of Interest Rate Strategy for Bear, Stearns and Co., where he gained extensive experience in OTC derivatives. He also worked as an Adjunct Professor in Portfolio Theory Economics at the University of Illinois.


Boberski earned bachelor's degrees in economics and finance from the College of William and Mary, a master's degree in economics from the University of Chicago and a master's degree in finance from the University of Illinois. He has published two books and has been named to the Institutional Investor All-American Research Team. He is a Series 3, 7, 16 and 63 Registered Representative.


CME Group ( is the world's largest and most diverse derivatives exchange. Building on the heritage of CME, CBOT and NYMEX, CME Group serves the risk management needs of customers around the globe. As an international marketplace, CME Group brings buyers and sellers together on the CME Globex electronic trading platform and on trading floors in Chicago and New York. By acting as the buyer to every seller and the seller to every buyer, CME Clearing virtually eliminates counterparty credit risk. CME Clearing also offers financial safeguards to help mitigate systemic risk, providing the security and confidence market participants need to operate, invest and grow. CME Group offers the widest range of benchmark products available across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, and alternative investment products such as weather and real estate. CME Group is listed on NASDAQ under the symbol "CME."


The Globe logo, CME, Chicago Mercantile Exchange, CME Group, Globex, E-mini and CME ClearPort are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of the Board of Trade of the City of Chicago. NYMEX and New York Mercantile Exchange are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. All other trademarks are the property of their respective owners. Further information about CME Group and its products can be found at



Web site:

Corporate Communications

+1 312 930 3434